Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Practical Strategies for Patients and Caregivers to Minimize Reactions with Subcutaneous Immune Globulin (SCIG)

Providing clear and concise information for patients receiving subcutaneous immune globulin (SCIG) therapy, is of utmost importance. SCIG treatments can be life-changing for people with immune deficiencies and autoimmune conditions; localized site reactions are anticipated and generally well-tolerated and should not be considered a contraindication to treatment continuation. In this blog, I will share some practical strategies to help minimize these reactions and hopefully improve the overall experience for patients and caregivers. Typical localized site reactions include but are not limited to burning, itching, redness, swelling, and pain to injection sites. These reactions should minimize over time once the body gets used to the drug. [More]

Managing IVIG-Related Side Effects

Intravenous Immune Globulin (IVIG) infusions are generally well tolerated. Most associated side effects are mild and managed with multiple approaches which may include pre-medication, clinical consultation providing education on what to expect with infusion, ongoing monitoring of infusions, and modifications to the individualized patient infusion protocol if side effects occur. [More]

Who To Call and When: A Guide to Communication With The MD and Pharmacist Part 1

By Michelle Greer, RN, IgCN.

In the support of our patients in the homecare setting, it is imperative as nurses that we know when to notify the physician and pharmacist for patients receiving immune globulin therapy. IG therapy does have side effects, and it is important to recognize them and know what to do. Every patient will react differently to IG therapy. Some patients may experience no side effects at all, while others may have mild to moderate reactions. This goes for both IV and SC therapy. The management of IVIG and SCIG infusion side effects is crucial to the overall tolerability of IG therapy. [More]